USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Hybridization of Clinical Trial Designs Reviving Global CRO Market Post-pandemic, 2019–2024
Hybridization of Clinical Trial Designs Reviving Global CRO Market Post-pandemic, 2019–2024
Patient-centric and Safety-focused Logistical Solutions will Create New Growth Opportunities
21-Aug-2020
Global
$4,950.00
Special Price $3,712.50 save 25 %
Description
In this research deliverable, Frost & Sullivan’s analyst team offers a bold perspective on the post-pandemic growth opportunities for the global CRO market. With the increased threat of COVID-19 and world-wide lockdowns in effect, the contract research organization (CROs) market is seeing interruptions in ongoing clinical trials and delays of new trials. This research service will help participants plan their production pipeline and be well prepared to tackle the dynamic market situation and the post-COVID-19 impact. This short report covers the Global Contract Research Organization Market (CRO) insights, with forecast for the total CRO market, including drug discovery and preclinical markets, with 2019 as the base year and 2020–2024 as the forecast period. Market revenue is measured in US dollars. It presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides global, post-pandemic revenue forecasts for CROs. Further, qualitative information will be provided on support services, such as central laboratory services, bioanalytics, and data management. The report identifies strong CRO opportunities, with the evolving digitized ecosystem of the clinical trials due to COVID-19. The two key market trends identified are increased adoption of hybrid clinical trials and remote patient monitoring.
Research Highlights
- Pre-/post-COVID-19 impact and growth trajectory of the CRO market
- Future market outlook and underlying trends
- Major growth opportunities
Author: Khushbu Jain
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Revised State of the CRO Market Due to the Pandemic
Key Forecast Criteria
Scope and Segmentation
Total Market Revenue Forecast
Total Market Revenue Forecast—Original and Revised Forecast Comparison
Drug Discovery and Preclinical CRO Revenue Forecast
Drug Discovery and Preclinical CRO Market—Post-COVID-19 Revenue Scenario
Clinical Segment Revenue Forecast
Distribution of Disrupted Trial Sites
COVID-19 Trials by Regions and Phases
Disrupted Trials—Discussion
Revenue Forecast by Peripheral Segments
Other Forecast Trends
Policy and Regulations
Policy and Regulations (continued)
Policy and Regulations (continued)
Global CRO Market Future Outlook
Global CRO Market Future Outlook (Continued)
Growth Opportunity 1: Clinical Trials for Digital Therapeutics, 2019
Growth Opportunity 1: Clinical Trials for Digital Therapeutics, 2019 (continued)
Growth Opportunity 2: Clinical Trial IT Solutions for RPM and Telemedicine, 2019
Growth Opportunity 2: Clinical Trial IT Solutions for RPM and Telemedicine, 2019 (continued)
Growth Opportunity 3: Logistical Solutions for Direct-to-Consumer Approach, 2019
Growth Opportunity 3: Logistical Solutions for Direct-to-Consumer Approach, 2019 (continued)
About the Growth Pipeline Engine™
Next Steps
List of Exhibits
Legal Disclaimer
Popular Topics
Research Highlights
- Pre-/post-COVID-19 impact and growth trajectory of the CRO market
- Future market outlook and underlying trends
- Major growth opportunities
Author: Khushbu Jain
| No Index | No |
|---|---|
| Podcast | No |
| Author | Khushbu Jain |
| Industries | Healthcare |
| WIP Number | PB21-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9611-B1 |